Xu Che

2.6k citations

81 papers · 1.2k indexed · h-index 15

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in ⓘ

Oncology 45
- Pancreatic and Hepatic Oncology Research 35
Surgery 31
- Cholangiocarcinoma and Gallbladder Cancer Studies 14

Co-authors: Dianke Yu (2 shared papers)Dongxin Lin (2 shared papers)Chengfeng Wang (2 shared papers)Chen Wu (2 shared papers)Wen Tan (2 shared papers)Li Wang (1 shared paper)Tongwen Zhang (1 shared paper)Jian Xu (1 shared paper)
Journals: Frontiers in Oncology (12 papers)World Journal of Gastroenterology (3 papers)HPB (2 papers)World Journal of Surgical Oncology (2 papers)Medicine (2 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Xu Che

73 papers receiving 1.2k citations

Peers

Countries citing papers authored by Xu Che

Since Specialization

Citations

This map shows the geographic impact of Xu Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Che more than expected).

Fields of papers citing papers by Xu Che

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Che. The network helps show where Xu Che may publish in the future.

Co-authors

The 25 scholars most cited alongside Xu Che, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xu Che Line = papers co-authored together Xu Che links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis Molecular Carcinogenesis ·Jian Xu, Chen Wu, Xu Che, Li Wang, Dianke Yu, Tongwen Zhang, Liming Huang, Hui Li, Wen Tan, Chengfeng Wang, Dongxin Lin	2010	480
2	Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism Signal Transduction and Targeted Therapy ·Mengwen Zhang, Xingyi Pan, Kenji Fujiwara, Noelle R. Jurcak, Stephen Muth, Jiaojiao Zhou, Qian Xiao, Anqi Li, Xu Che, Zihai Li, Lei Zheng	2021	69
3	Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies Journal for ImmunoTherapy of Cancer ·Victoria M. Kim, Alex B. Blair, Peter Lauer, Kelly Foley, Xu Che, Kevin C. Soares, Tao Xia, Stephen Muth, Jennifer Kleponis, Todd D. Armstrong, Christopher L. Wolfgang, Elizabeth M. Jaffee, Dirk G. Brockstedt, Lei Zheng	2019	55
4	Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients HepatoBiliary Surgery and Nutrition ·Pingzhou Yang, Milind Javle, Fei Pang, Zhao Wei, Reham Abdel‐Wahab, Xiaofeng Chen, Funda Meric‐Bernstam, Huanwei Chen, Mitesh J. Borad, Yu Liu, Chuntao Zou, Shuo Mu, Yutong Xing, Kai Wang, Chuang Peng, Xu Che	2019	36
5	Anorectal malignant melanomas: Retrospective experience with surgical management World Journal of Gastroenterology ·Xu Che	2011	34
6	DNA methylation in the tumor microenvironment Journal of Zhejiang University SCIENCE B ·Mengwen Zhang, Kenji Fujiwara, Xu Che, Shu Zheng, Lei Zheng	2017	34
7	Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment Molecular Cancer Therapeutics ·Agnieszka A. Rucki, Qian Xiao, Stephen Muth, Jianlin Chen, Xu Che, Jennifer Kleponis, Rajni Sharma, Robert A. Anders, Elizabeth M. Jaffee, Lei Zheng	2017	28
8	Effect of indocyanine green fluorescence angiography on preventing anastomotic leakage after colorectal surgery: a meta-analysis Surgery Today ·Wei Zhang, Xu Che	2021	26
9	Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study Frontiers in Oncology ·Xiaozhun Huang, Lin Xu, Teng Ma, Xin Yin, Zhangkan Huang, Yihong Ran, Ni Yong, Xinyu Bi, Xu Che	2021	24
10	Identification of Genomic Alterations in Pancreatic Cancer Using Array-Based Comparative Genomic Hybridization PLoS ONE ·Jianwei Liang, Zhi‐Zhou Shi, Tianyun Shen, Xu Che, Zheng Wang, Susheng Shi, Xin Xu, Yan Cai, Ping Zhao, Chengfeng Wang, Zhixiang Zhou, Ming‐Rong Wang	2014	21
11	Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine Theranostics ·Xudong Huang, Jian Zheng, Jun Li, Xu Che, Wenle Tan, Wen Tan, Mingming Shao, Xinxin Cheng, Zhongli Du, Yanjie Zhao, Chengfeng Wang, Chen Wu, Dongxin Lin	2018	20
12	Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients Scientific Reports ·Shuisheng Zhang, Chengfeng Wang, Huang Huang, Qinglong Jiang, Dongbing Zhao, Yantao Tian, Jie Ma, Wei Yuan, Yuemin Sun, Xu Che, Jianwei Zhang, Haibo Chen, Yajie Zhao, Yunmian Chu, Yawei Zhang, Yingtai Chen	2017	17
13	Safety and efficacy of robot-assisted versus open pancreaticoduodenectomy: a meta-analysis of multiple worldwide centers Updates in Surgery ·Wei Zhang, Zhangkan Huang, Jianwei Zhang, Xu Che	2020	17
14	Long-term results of intraoperative electron beam radiation therapy for nonmetastatic locally advanced pancreatic cancer Medicine ·Yingtai Chen, Xu Che, Jianwei Zhang, Huang Huang, Dongbing Zhao, Yantao Tian, Ye‐Xiong Li, Qinfu Feng, Zhihui Zhang, Qinglong Jiang, Shuisheng Zhang, Xiaolong Tang, Xianghui Huang, Yunmian Chu, Jianghu Zhang, Yuemin Sun, Yawei Zhang, Chengfeng Wang	2016	16
15	The Clinicopathological Features and Long-Term Survival Outcomes of Mucinous Gastric Carcinoma: a Consecutive Series of 244 Cases from a Single Institute Journal of Gastrointestinal Surgery ·Xiaolong Tang, Jianwei Zhang, Xu Che, Zhongmin Lan, Yingtai Chen, Chengfeng Wang	2016	14
16	Experts’ consensus on intraoperative radiotherapy for pancreatic cancer Cancer Letters ·Ye‐Xiong Li, Qinfu Feng, Jing Jin, Susheng Shi, Zhihui Zhang, Xu Che, Jianwei Zhang, Yingtai Chen, Xiuhong Wu, Rufu Chen, Shengping Li, Jing Wang, Guang Li, Fei Li, Menghua Dai, Lei Zheng, Chengfeng Wang	2019	12
17	Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review Frontiers in Oncology ·Wei Zhang, Deliang Ouyang, Zhangkan Huang, Xu Che	2023	12
18	Effect of polyglycolic acid mesh for prevention of pancreatic fistula after pancreatectomy Medicine ·Wei Zhang, Zhicheng Wei, Xu Che	2020	12
19	Clinicopathologic features, surgical treatments, and outcomes of small bowel tumors: A retrospective study in China International Journal of Surgery ·Shuisheng Zhang, Cuiling Zheng, Yingtai Chen, Quan Xu, Jie Ma, Wei Yuan, Qinglong Jiang, Yajie Zhao, Jianwei Zhang, Xu Che, Chengfeng Wang, Xiaozhun Huang, Fang Chen, Nianchang Wang, Xiao Ma, Zhongmin Lan	2017	11
20	Impact of body mass index on complications following pancreatectomy: Ten-year experience at National Cancer Center in China World Journal of Gastroenterology ·Yingtai Chen, Qian Deng, Xu Che, Jianwei Zhang, Yuheng Chen, Dongbin Zhao, Yantao Tian, Yawei Zhang, Chengfeng Wang	2015	11

About Xu Che

Xu Che is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 81 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Genomics and Diagnostics (9 papers), Gastric Cancer Management and Outcomes (9 papers), Gallbladder and Bile Duct Disorders (8 papers), Cancer Research and Treatments (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Cancer Research (523 citations), Hepatology (136 citations), Oncology (373 citations), Molecular Biology (603 citations) and Pulmonary and Respiratory Medicine (188 citations). Xu Che has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dianke Yu, Dongxin Lin, Chengfeng Wang, Chen Wu, Wen Tan, Li Wang, Tongwen Zhang, Jian Xu, Hui Li and Liming Huang. Their work appears in journals such as Frontiers in Oncology, World Journal of Gastroenterology, HPB, World Journal of Surgical Oncology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact